Yorktown Management & Research Company’s Bristol-Myers Squibb BMY Stock Holding History

Yorktown Management & Research Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,930	Closed	-$233K	–	252
2021 Q3	$233K	Hold	3,930	–	–	0.18%	238
2021 Q2	$263K	Hold	3,930	–	–	0.21%	204
2021 Q1	$248K	Sell	3,930 -2,500	-39%	-$156K	0.21%	192
2020 Q4	$399K	Buy	6,430 +810	+14%	+$49.8K	0.36%	134
2020 Q3	$339K	Buy	5,620 +420	+8%	+$25.3K	0.32%	156
2020 Q2	$306K	Sell	5,200 -8,500	-62%	-$508K	0.27%	177
2020 Q1	$764K	Buy	13,700 +300	+2%	+$18.3K	0.77%	19
2019 Q4	$860K	Hold	13,400	–	–	0.46%	78
2019 Q3	$680K	Buy	+13,400	New	+$630K	0.37%	89
2019 Q1	–	Sell	-20,000	Closed	-$1.04M	–	317
2018 Q4	$1.04M	Hold	20,000	–	–	0.34%	75
2018 Q3	$1.24M	Buy	20,000 +16,000	+400%	+$950K	0.36%	77
2018 Q2	$221K	Buy	+4,000	New	+$216K	0.06%	334
2016 Q3	–	Sell	-3,000	Closed	-$221K	–	295
2016 Q2	$221K	Buy	+3,000	New	+$212K	0.05%	255
2016 Q1	–	Sell	-3,000	Closed	-$206K	–	368
2015 Q4	$206K	Buy	+3,000	New	+$198K	0.04%	362
2015 Q3	–	Sell	-3,000	Closed	-$200K	–	459
2015 Q2	$200K	Buy	+3,000	New	+$198K	0.04%	449
2015 Q1	–	Sell	-4,500	Closed	-$266K	–	479
2014 Q4	$266K	Sell	4,500 -1,200	-21%	-$67.7K	0.06%	234
2014 Q3	$292K	Hold	5,700	–	–	0.06%	176
2014 Q2	$277K	Hold	5,700	–	–	0.05%	255
2014 Q1	$296K	Hold	5,700	–	–	0.06%	198
2013 Q4	$303K	Sell	5,700 -800	-12%	-$40.8K	0.06%	180
2013 Q3	$301K	Hold	6,500	–	–	0.06%	163
2013 Q2	$290K	Buy	+6,500	New	+$282K	0.06%	150

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Yorktown Management & Research Company's BMY Position: Q4 2021 in Review

Yorktown Management & Research Company sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 3,930 shares — an estimated $233K sold.

Yorktown Management & Research Company first reported a position in BMY in Q2 2013 and held it in 22 quarters. The position peaked at $1.24M in Q3 2018. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Yorktown Management & Research Company reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Yorktown Management & Research Company sold 3,930 Bristol-Myers Squibb shares in Q4 2021, an estimated $233K.
Yorktown Management & Research Company first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 22 quarters.
Yorktown Management & Research Company's Bristol-Myers Squibb position peaked at $1.24M in Q3 2018.
2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Yorktown Management & Research Company's 13F filing for Q4 2021, filed 9 Feb 2022.